lamivudine has been researched along with Hepatitis in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (77.78) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berg, CL; Coffin, CS; Curry, MP; Dove, LM; Nissen, NN; Ragni, M; Regenstein, FG; Roland, ME; Sherman, KE; Stock, PG; Terrault, NA | 1 |
| Asaka, M; Imamura, M; Masauzi, N; Tanaka, J; Tsutsumi, Y; Yamamoto, Y | 1 |
| Razonable, RR | 1 |
| Chan, TM; Ho, SK; Lai, KN; Tang, CS; Tse, KC | 1 |
| Chang, WW; Chen, CL; Cheng, JT; Fan, CW; Lin, YS; Lo, HY; Tsao, CW; Wu, SR | 1 |
| Fätkenheuer, G; Lehmann, C; Wyen, C | 1 |
| Chan-Tack, KM; Edozien, A | 1 |
| Akuta, N; Arase, Y; Hosaka, T; Ikeda, K; Kobayashi, M; Kumada, H; Saitoh, S; Sezaki, H; Someya, T; Suzuki, F; Suzuki, Y | 1 |
| Bock, CT; Böker, KH; Flemming, P; Glomb, I; Klempnauer, J; Krüger, M; Manns, MP; Tillmann, HL; Trautwein, C | 1 |
2 review(s) available for lamivudine and Hepatitis
| Article | Year |
|---|---|
Prevention of hepatitis B virus reactivation under rituximab therapy.
Topics: Animals; Antibodies, Monoclonal, Murine-Derived; Arthritis, Rheumatoid; Hepatitis; Hepatitis B Antibodies; Hepatitis B virus; Humans; Immunosuppression Therapy; Lamivudine; Lymphoma, Non-Hodgkin; Purpura, Thrombocytopenic, Idiopathic; Rituximab; Virus Activation; Virus Replication | 2009 |
Antiviral drugs for viruses other than human immunodeficiency virus.
Topics: Acyclovir; Adenine; Amantadine; Antiviral Agents; Comorbidity; Drug Therapy, Combination; Foscarnet; Ganciclovir; Guanine; Hepatitis; Hepatitis B, Chronic; Hepatitis C; Herpesviridae Infections; HIV Infections; Humans; Influenza, Human; Interferons; Lamivudine; Nucleosides; Oligopeptides; Organophosphonates; Oseltamivir; Proline; Protease Inhibitors; Pyrimidinones; Ribavirin; Telbivudine; Thymidine; Valacyclovir; Valganciclovir; Valine; Virus Replication; Zanamivir | 2011 |
7 other study(ies) available for lamivudine and Hepatitis
| Article | Year |
|---|---|
Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients.
Topics: Adult; Aged; Antiviral Agents; Graft Survival; Hepatitis; Hepatitis B; Hepatitis B virus; HIV; HIV Infections; Humans; Immunoglobulins; Immunologic Deficiency Syndromes; Infections; Lamivudine; Liver Cirrhosis; Liver Failure; Liver Transplantation; Longitudinal Studies; Male; Middle Aged; Secondary Prevention; Treatment Outcome; Virus Diseases; Viruses | 2010 |
Prospective study on lamivudine-resistant hepatitis B in renal allograft recipients.
Topics: Adult; Aged; Alanine Transaminase; Amino Acid Motifs; Codon; DNA Mutational Analysis; DNA, Viral; Drug Resistance, Viral; Female; Follow-Up Studies; Hepatitis; Hepatitis B; Hepatitis B virus; Humans; Immunosuppressive Agents; Kidney Transplantation; Lamivudine; Male; Middle Aged; Prospective Studies; Reverse Transcriptase Inhibitors; Time Factors | 2004 |
Serotonin transporter mRNA expression is decreased by lamivudine and ribavirin and increased by interferon in immune cells.
Topics: Antiviral Agents; Blotting, Western; Depression; Gene Expression Regulation; Hepatitis; Humans; Interferon-alpha; Jurkat Cells; Lamivudine; Leukocytes, Mononuclear; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; RNA, Messenger; RNA, Viral; Serotonin; Serotonin Plasma Membrane Transport Proteins; T-Lymphocytes; U937 Cells | 2006 |
Rapid improvement of liver function in a patient with HIV and hepatitis B coinfection treated with lamivudine and tenofovir.
Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; Hepatitis; HIV Infections; Humans; Lamivudine; Liver Function Tests; Organophosphonates; Tenofovir; Zidovudine | 2006 |
Lamivudine monotherapy in an HIV-infected patient with the M184V mutation.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Hepatitis; HIV Infections; HIV-1; Humans; Hypertriglyceridemia; Lamivudine; Male; Middle Aged | 2006 |
Factors associated with the virological response of lamivudine-resistant hepatitis B virus during combination therapy with adefovir dipivoxil plus lamivudine.
Topics: Adenine; Adult; Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Multivariate Analysis; Organophosphonates; Retrospective Studies; Reverse Transcriptase Inhibitors | 2007 |
Lamivudine transiently reduces viral load and improves liver function in liver transplant recipients with fibrosing cholestatic hepatitis.
Topics: Cholestasis; Hepatitis; Humans; Lamivudine; Liver; Liver Cirrhosis; Liver Transplantation; Reverse Transcriptase Inhibitors; Viral Load | 2002 |